← Back to Search

Behavioral Intervention

Mindfulness App for Smoking Cessation in Cancer Survivors

N/A
Waitlist Available
Led By Min-Jeong Yang, PhD
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Having been diagnosed with cancer
Be older than 18 years old
Must not have
Current use of smoking cessation medications
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 4 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to gather feedback on a new app designed to help cancer patients quit smoking.

Who is the study for?
This trial is for cancer survivors who smoke and are willing to try quitting. Participants must be able to use an app on their smartphone daily, speak English, and have smoked recently. They can't join if they're using other quit-smoking treatments, are pregnant or breastfeeding, or have current psychosis.
What is being tested?
The study tests a new quit-smoking treatment delivered through a prototype app designed for individuals with a cancer diagnosis. It aims to gather user feedback on the effectiveness of this mindfulness-based intervention.
What are the potential side effects?
Since the intervention involves using an app for smoking cessation support, there may not be direct side effects like those from medication; however, users might experience stress or frustration during the quitting process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently using medication to help me stop smoking.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Likability of mindfulness practices
Open-ended feedback
Retention rate
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Usability TestingExperimental Treatment1 Intervention
Participants will receive brief counseling, nicotine replacement therapy, and intervention content delivered via the app.

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
564 Previous Clinical Trials
144,871 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,938 Previous Clinical Trials
41,023,176 Total Patients Enrolled
Min-Jeong Yang, PhDPrincipal InvestigatorMoffitt Cancer Center
Christine Vinci, PhDPrincipal InvestigatorMoffitt Cancer Center
3 Previous Clinical Trials
2,689 Total Patients Enrolled
~3 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top